Lionel Breton
108Patents
23h-index
52Co-inventors
93Inventor score
Filing activity: Oct 2, 1995 → May 1, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5824650A | Topical composition containing a substance P antagoinst | Human Necessities | 120 | Expired |
| US6019967A | Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin | Human Necessities | 113 | Expired |
| US5733558A | Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same | Human Necessities | 109 | Expired |
| US6753000B2 | Hydroxystilbene/ascorbic acid compositions for treating skin afflictions | Human Necessities | 88 | Expired |
| US5851556A | Use of a salt of an alkaline-earth metal as TNF-A or substance P inhibitor in a topical composition and composition obtained | Human Necessities | 66 | Expired |
| US5993833A | Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition | Human Necessities | 61 | Expired |
| US5989568A | Cosmetic/dermatological skin care compositions comprising S-DHEA | Human Necessities | 58 | Expired |
| US6509014B1 | Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discreet erythema | Emerging Cross-Sectional Technologies | 58 | Expired |
| US5932215A | Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discrete erythema | Emerging Cross-Sectional Technologies | 38 | Expired |
| US7651680B2 | Methods and compositions for preventing and treating sensitive and dry skin | Human Necessities | 34 | Expired |
| US5869068A | Compositions and methods for treating wrinkles and/or fine lines of the skin | Human Necessities | 32 | Expired |
| US6048855A | Topical composition containing capsazepine | Human Necessities | 31 | Expired |
| US6060061A | Method for preventing or treating disorders involving an inflammatory process | Human Necessities | 29 | Expired |
| US6242229A | Cosmetic/pharmaceutical compositions comprising microorganism culture media | Human Necessities | 28 | Expired |
| US6147121A | Skin toning by stimulating collagen synthesis/proliferation of dermal fibroblasts | Human Necessities | 28 | Expired |
| US6168809A | Alkaline-earth metal salt for the treatment of ocular or palpebral pruritus and dysesthesia | Human Necessities | 27 | Expired |
| US5679360A | Substance P antagonist for the treatment of lichens, prurigo, pruritus | Human Necessities | 26 | Expired |
| US5935586A | Therapeutic/cosmetic compositions comprising CGRP antagonists for treating disease states of the skin | Human Necessities | 25 | Expired |
| US7547527B2 | Use of probiotic lactic acid bacteria for balancing the skin's immune system | Human Necessities | 24 | Expired |
| US5900257A | Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists | Human Necessities | 24 | Expired |
| US5795574A | Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it | Human Necessities | 24 | Expired |
| US6440433B1 | Hydroxystilbene/ascorbic acid compositions for treating skin afflictions | Human Necessities | 24 | Expired |
| US5976559A | Compositions and methods for treating wrinkles and/or fine lines of the skin | Human Necessities | 23 | Expired |
| US5858024A | Composition for dyeing keratin fibres containing a substance P antagonist | Human Necessities | 23 | Expired |
| US6344438B1 | Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids | Human Necessities | 23 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.